Effect of Two Doses of Olmesartan Medoxomil and Amlodipine on Vascular Markers in Hypertensive Patients With Metabolic Syndrome

Clinical trial NCT00891267 · COMPLETED

Trial details

NCT number: NCT00891267
Sponsor: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Metabolic Syndrome Hypertension

Start date: 2008-10-01
Primary completion: 2011-04-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.